We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Epam (EPAM) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Epam (EPAM - Free Report) will report quarterly earnings of $2.27 per share in its upcoming release, pointing to a year-over-year decline of 7.7%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 10.1% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 5.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some Epam metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts expect 'Revenues by Contract Type- Time-and-material' to come in at $1.08 billion. The estimate indicates a change of +10.3% from the prior-year quarter.
The consensus estimate for 'Revenues by Contract Type- Fixed-price' stands at $191.62 million. The estimate suggests a change of +8.7% year over year.
Analysts predict that the 'Revenues by Contract Type- Licensing and other revenues' will reach $10.48 million. The estimate indicates a year-over-year change of +37.6%.
Over the past month, Epam shares have recorded returns of +10.9% versus the Zacks S&P 500 composite's +0.4% change. Based on its Zacks Rank #4 (Sell), EPAM will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Seeking Clues to Epam (EPAM) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts forecast that Epam (EPAM - Free Report) will report quarterly earnings of $2.27 per share in its upcoming release, pointing to a year-over-year decline of 7.7%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 10.1% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 5.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some Epam metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts expect 'Revenues by Contract Type- Time-and-material' to come in at $1.08 billion. The estimate indicates a change of +10.3% from the prior-year quarter.
The consensus estimate for 'Revenues by Contract Type- Fixed-price' stands at $191.62 million. The estimate suggests a change of +8.7% year over year.
Analysts predict that the 'Revenues by Contract Type- Licensing and other revenues' will reach $10.48 million. The estimate indicates a year-over-year change of +37.6%.
View all Key Company Metrics for Epam here>>>
Over the past month, Epam shares have recorded returns of +10.9% versus the Zacks S&P 500 composite's +0.4% change. Based on its Zacks Rank #4 (Sell), EPAM will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>